Q32 Bio Inc.(QTTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

QTTB Q32 Bio Inc.

Trading 07-07 12:39:56 EDT

13.45

+0.58

+4.51%

High13.48	Low12.66	Vol109.56K
Open12.92	D1 Closing12.87	Amplitude6.38%
Mkt Cap227.98M	Tradable Cap116.38M	Total Shares16.96M
T/O1.43M	T/O Rate1.27%	Tradable Shares8.66M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"QTTB","market":"US","secType":"STK","nameCN":"Q32 Bio Inc.","latestPrice":13.445,"timestamp":1783442385037,"preClose":12.865,"halted":0,"volume":109555,"delay":0,"changeRate":0.04508356004663817,"floatShares":8656200,"shares":16956415,"eps":2.652,"marketStatus":"Trading","change":0.58,"latestTime":"07-07 12:39:56 EDT","open":12.92,"high":13.48,"low":12.6596,"amount":1425271.4388650001,"amplitude":0.06377,"askPrice":13.47,"askSize":4,"bidPrice":13.38,"bidSize":579,"shortable":3,"etf":0,"ttmEps":2.652,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1783454400000},"marketStatusCode":2,"adr":0,"listingDate":1522209600000,"exchange":"NASDAQ","adjPreClose":12.865,"preHourTrading":{"tag":"盘前","latestPrice":12.97,"preClose":12.865,"latestTime":"09:10 EDT","volume":735,"amount":9552.401039999999,"timestamp":1783429819887,"change":0.105,"changeRate":0.008162,"amplitude":0.00206},"postHourTrading":{"tag":"盘后","latestPrice":12.865,"preClose":12.865,"latestTime":"18:22 EDT","volume":1207,"amount":15533.115,"timestamp":1783376521337,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.602647,"impliedVol":1.5701,"impliedVolPercentile":0.9211},"requestUrl":"/m/hq/s/QTTB","defaultTab":"news","newsList":[{"id":"2646389010","title":"Q32 Bio Files $300 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2646389010","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646389010?lang=en_us&edition=fundamental","pubTime":"2026-06-26 05:46","pubTimestamp":1782423981,"startTime":"0","endTime":"0","summary":"Q32 Bio  filed a registration statement Thursday for the potential sale of up to $300 million in securities from time to time in one or more offerings.The filing covers common and preferred stock, debt securities, warrants and units.Net proceeds will be used for general corporate purposes, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646852283","title":"Q32 Bio files $300M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2646852283","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646852283?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:20","pubTimestamp":1782418859,"startTime":"0","endTime":"0","summary":"16:15 EDT Q32 Bio (QTTB) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/q32-bio-files-300m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/q32-bio-files-300m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646851683","title":"Q32 Bio - May Offer up to $300 Mln in Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2646851683","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646851683?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:12","pubTimestamp":1782418351,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42X0DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644767464","title":"Q32 Bio shareholders elected Class II directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2644767464","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644767464?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:02","pubTimestamp":1781640145,"startTime":"0","endTime":"0","summary":"At its 2026 annual shareholder meeting, Q32 Bio’s shareholders ratified Ernst & Young as auditor for the year ending Dec. 31, 2026.Shareholders also elected Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos as Class II directors, with terms running to the 2029 annual meeting.A separate advisory vote endorsed the company’s named executive officer compensation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q32 Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL9vtf4M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643222366","title":"Hansa Biopharma names Adam Cutler CFO, effective June 22","url":"https://stock-news.laohu8.com/highlight/detail?id=2643222366","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643222366?lang=en_us&edition=fundamental","pubTime":"2026-06-15 13:01","pubTimestamp":1781499687,"startTime":"0","endTime":"0","summary":"Cutler joins from Mural Oncology; previously CFO at Q32 Bio, Molecular Templates.Evan Ballantyne, CFO since 2024, steps down June 22; remains until July 10 to support the transition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansa Biopharma AB published the original content used to generate this news brief on June 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL6Yk4B6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640995610","title":"Q32 Bio director and 10% owner Diyong Xu acquires $15 million in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995610","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640995610?lang=en_us&edition=fundamental","pubTime":"2026-06-02 09:16","pubTimestamp":1780362991,"startTime":"0","endTime":"0","summary":"Q32 Bio director Xu Diyong reported purchases of 1.88 million common shares at $8 per share in a private placement.Indirect holdings rose to 3,502,987 shares in one account, with a separate indirect position of 625,000 shares reported.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q32 Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL3Z0f5l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640499555","title":"OrbiMed Advisors acquires Q32 Bio common shares worth $15 million in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640499555","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640499555?lang=en_us&edition=fundamental","pubTime":"2026-06-02 09:13","pubTimestamp":1780362813,"startTime":"0","endTime":"0","summary":"OrbiMed Advisors, a director and 10% owner, bought 1.88 million Q32 Bio common shares in a private placement at USD 8 each.Indirect beneficial ownership rose to 3.5 million shares held via OrbiMed Private Investments VII.A separate OrbiMed Genesis position totaled 625,000 shares following the purchase.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q32 Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDLGmG10:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"OrbiMed Advisors acquires Q32 Bio common shares worth $15 million in private placement","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638687010","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2638687010","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638687010?lang=en_us&edition=fundamental","pubTime":"2026-05-28 01:39","pubTimestamp":1779903575,"startTime":"0","endTime":"0","summary":"Astrotech  shares soared 511% amid heavy trading after the company's board approved an initiative aimed at evaluating emerging opportunities associated with Moon-based quantum computing manufacturing.More than 113.6 million shares of the company traded intraday compared with a daily average of about 2.12 million.Q32 Bio  said Wednesday it agreed to raise about $55 million through a private placement with institutional and accredited investors.Shares soared 70% amid a surge in intraday trading volume to over 18.0 million from a daily average of roughly 322,000.Dycom Industries  reported fiscal Q1 adjusted net income and contract revenue above market expectations on Wednesday. It also increased the fiscal 2027 guidance for contract sales, beating consensus.Shares advanced 31% as intraday trading volume rose to over 861,000 from a daily average of about 439,000.Price: 547.30, Change: +126.83, Percent Change: +30.16","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DY","BK4187","BK4129","QTTB","BK4139","BK4157","ASTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638373684","title":"Q32 Bio Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2638373684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638373684?lang=en_us&edition=fundamental","pubTime":"2026-05-27 23:26","pubTimestamp":1779895581,"startTime":"0","endTime":"0","summary":"09:37 EDT Q32 Bio (QTTB) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/q32-bio-inc-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/q32-bio-inc-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638143689","title":"Q32 Bio announces $55M private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2638143689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638143689?lang=en_us&edition=fundamental","pubTime":"2026-05-27 22:40","pubTimestamp":1779892800,"startTime":"0","endTime":"0","summary":"Q32 Bio (QTTB) announced that it has entered into a securities purchase agreement with certain new and existing institutional and accredited invest...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/q32-bio-announces-55m-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/q32-bio-announces-55m-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638588685","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:32 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2638588685","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638588685?lang=en_us&edition=fundamental","pubTime":"2026-05-27 21:32","pubTimestamp":1779888724,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:32 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nAQN2M0R8R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638683535","title":"BUZZ-U.S. STOCKS ON THE MOVEd-Micron, Abercrombie & Fitch, Q32 Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2638683535","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638683535?lang=en_us&edition=fundamental","pubTime":"2026-05-27 21:04","pubTimestamp":1779887095,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVEd-Micron, Abercrombie & Fitch, Q32 BioWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call news","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nL6N4240LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MULL","LU0417517546.SGD","IE000M9KFDE8.USD","LU2381873111.SGD","BK4533","BK4527","FLY","LU2054465674.USD","LU0471298777.SGD","IE00B19Z3B42.SGD","LU1732799900.SGD","LU2471134879.HKD","LU0980610538.SGD","HIMZ","LU2430703251.USD","LU0205194284.USD","IE0034235303.USD","MUU","LU1084165304.USD","BK4551","LU1852331112.SGD","LU2462591277.SGD","LU0345770308.USD","XOMO","BK4550","LU0878866978.SGD","LU0170899867.USD","BK4152","LU0061474960.USD","LU0274383776.USD","LU0433182093.SGD","LU0345781412.USD","LU0942090050.USD","LU0719512351.SGD","LU0648000940.SGD","LU1861214812.USD","LU1582986433.USD","LU2129689514.USD","SMTC","LU0868494617.USD","LU1430597077.USD","LU2505996681.GBP","LU0683600562.USD","SG9999015341.SGD","LU1496350502.SGD","LU2065171402.SGD","LU1366333091.USD","ZS","LU0466842654.USD","LU1506573853.SGD","LU2462611646.USD","LU1267930813.SGD","LU1430594728.SGD","BK4561","IE0004445239.USD","LU0312595415.SGD","BK4570","LU1150488135.SGD","LU1116320901.HKD","LU2065170008.USD","LU2324357040.USD","LU2357627491.SGD","FPS","BK4512","LU2458330169.SGD","DE","IE00B19Z3581.USD","LU0012050646.USD","SG9999011175.SGD","LU0795875086.SGD","LU0323240290.USD","MGM","LU0265550946.USD","LU2286300806.USD","LU0612318385.USD","LU1929549753.HKD","LU0130102774.USD","BK4579","LU0477156953.USD","LU0210528500.USD","LU2491050071.SGD","LU1571399168.USD","LU2102340556.USD","LU0053671581.USD","LU0098860793.USD","LU2211815571.USD","LU0742534661.SGD","BK4516","LU0053666078.USD","FLYT","LU0345770993.USD","LU1989763690.USD","LU1066051498.USD","BK4543","HMYY","LU0211328371.USD","LU1883866441.USD","LU1582987324.SGD","LU0390134368.USD","LU0082616367.USD","LU2168564222.USD","LU2999663052.SGD","LU2125154935.USD","LU0278409577.USD","IE0009356076.USD","BK4023","BK4139","LU1069347547.HKD","LU1201861249.SGD","LU2023250843.SGD","BK4141","LU1815333072.USD","COP","LU0289961442.SGD","SG9999003800.SGD","IE00B2Q91V27.USD","LU0985489474.SGD","LU0256331488.USD","LU0385154629.USD","LU1150488218.USD","LU0122376428.USD","LU2211817866.USD","LU1582987597.SGD","LU2360106780.USD","IE00B5949003.HKD","LU1923622291.USD","IE00B3CCJ963.GBP","LU2931357623.SGD","LU2087621335.USD","BK4560","IE00BFXG1179.USD","LU0251142724.SGD","LU0612318971.USD","LU1323610961.USD","LU2237438978.USD","LU0345780950.USD","SG9999002232.USD","LU1988902786.USD","SG9999004303.SGD","LU1496350171.SGD","LU2168564149.EUR","LU0203345920.USD","LU2264538146.SGD","LU1548497426.USD","LU0788109394.HKD","LU0889566641.SGD","LU2471134523.USD","LU1989763427.SGD","LU0310799852.SGD","LU2592432038.USD","LU0106261612.USD","LU2505996509.AUD","MU","LU0234572021.USD","LU0630314457.HKD","LU0143551892.USD","LU2125909916.SGD","LU1894683264.USD","CVX","LU1861219969.SGD","BK4202","PODD","APGE","LU0205193047.USD","IE00BGHQF524.EUR","LU0048573561.USD","SG9999001440.SGD","LU0289960550.SGD","LU1778281490.HKD","LU2023250504.SGD","ANF","LU0056508442.USD","BK4575","FANG","LU0157215616.USD","LU0640476718.USD","LU2168564495.EUR","LU2106854487.HKD","XOMX","BK4187","BK4200","LU0149725797.USD","LU1585245621.USD","LU0256863811.USD","LU0320765489.SGD","LU0320765646.SGD","LU0127658192.USD","LU0642271901.SGD","LU2750360641.GBP","IE00BD6J9T35.USD","IE00B1XK9C88.USD","LU2458330243.SGD","LU2498475776.HKD","LU2430703178.SGD","LU0130517989.USD","QTTB","SGXZ23171101.USD","LU1201861165.SGD","LU2065169927.USD","SG9999014567.USD","LU2089985449.USD","LU2129689605.HKD","LU0368265418.SGD","HIMS","SG9999014542.SGD","LU0511384066.AUD","LU2471134796.USD","LU1162221912.USD","LU2357305700.SGD","IE00BZ1G4Q59.USD","LU2430703095.HKD","BK4150","LU1582986359.USD","MUD","IE0002270589.USD","LU1914381329.SGD","LU2048586759.USD","LU0130103400.USD","LU0203347892.USD","PONX","LU0912757837.SGD","LU2602419157.SGD","LU0289739343.SGD","SG9999014575.USD","LU2133065610.SGD","LU1261432733.SGD","LU0251131958.USD","LU1803068979.SGD","LU2491050154.USD","LU2750360997.AUD","BK4182","LU1732800096.USD","LU1720051108.HKD","LU2125909759.SGD","LU1974910355.USD","LU2543165471.USD","LU1674673428.USD","GB00BDT5M118.USD","LU0266512473.USD","BK4588","LU2954938101.SGD","BK4094","LU2125154778.USD","LU1280957306.USD","SG9999002224.SGD","LU0266512127.USD","LU1074936037.SGD","PONY","IE00BWXC8680.SGD","LU0265550359.USD","LU0154236417.USD","BK4581","LU1894683348.USD","SG9999002521.SGD","IE00BKVL7J92.USD","LU2250418816.HKD","LU0211327993.USD","LU0654597011.USD","BBWI","LU1267930490.SGD","LU2394011477.USD","LU0728928796.USD","IE00B7SZLL34.SGD","LU0208291251.USD","LU2168564065.EUR","LU0300736492.USD","SG9999015358.SGD","LU1674673691.USD","IE00B1BXHZ80.USD","LU1718418525.SGD","LU0859254822.USD","BK4097","LU0795875169.SGD","LU1119994496.HKD","LU1316542783.SGD","BK4605","LU1720051017.SGD","LU1839511570.USD","IE00BKDWB100.SGD","DKS","LU0868494708.USD","BK4553","LU0070302665.USD","SG9999014559.SGD","LU0957791311.USD","BK4554","IE00BZ199S13.USD","LU0300736062.USD","BK4566","BK4196","LU0456854461.SGD","HIMY","BK4585","LU0314106906.USD","CPRI","LU0889565833.HKD","LU0648001328.SGD","BK4559","HIYY","LU0109392836.USD","LU1064131342.USD","LU2487616109.SGD","LU0787776722.HKD","BK4213","LU1066053197.SGD","LU1489326972.SGD","LU0238689110.USD","LU2065171311.SGD","LU2491049909.HKD","BK4592","LU2360032135.SGD","BK4534","LU0175139822.USD","LU2471134952.CNY","BK4201","LU1917777945.USD","XOM","LU2347655156.SGD","LU0068578508.USD","LU0792757196.USD","BK4532","LU1116320737.USD","LU0081259029.USD","LU1035773651.USD","LU2168563687.JPY","BK4082","02026","LU2129689431.USD","LU0070217475.USD","XOMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638350744","title":"Q32 Bio prices USD 55 million private placement at USD 8 a share","url":"https://stock-news.laohu8.com/highlight/detail?id=2638350744","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638350744?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:02","pubTimestamp":1779883338,"startTime":"0","endTime":"0","summary":"Q32 Bio priced a private placement of common stock and pre-funded warrants with expected gross proceeds of about USD 55 million.Deal includes 6,725,000 common shares at USD 8 per share, pre-funded warrants for 150,000 shares priced at USD 8.Closing expected May 28, 2026, subject to customary conditions.BVF Partners led the financing; RA Capital Management, OrbiMed, Atlas Venture participated.Morgan Stanley served as lead placement agent; Oppenheimer also acted as placement agent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL7Lt5J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875086.SGD","BK4585","LU1244550494.USD","LU1720051017.SGD","LU0158827948.USD","BK4588","LU0528227936.USD","LU2089284900.SGD","LU0106261372.USD","LU1732799900.SGD","LU0234570918.USD","LU0225283273.USD","LU0882574139.USD","LU1064131342.USD","LU2089283258.USD","LU1244550577.SGD","LU0320765646.SGD","LU0912757837.SGD","LU1732800096.USD","IE00BKVL7J92.USD","LU0210528500.USD","BK4139","LU1074936037.SGD","LU1720051108.HKD","LU0971096721.USD","LU2111349929.HKD","BK4534","LU1989772840.SGD","LU0557290698.USD","LU1162221912.USD","LU2487616109.SGD","LU0795875169.SGD","LU0106831901.USD","LU1244550221.USD","LU1988902786.USD","LU0053666078.USD","BK4504","LU1363072403.SGD","LU2133065610.SGD","LU1791710582.SGD","LU2028103732.USD","LU0314104364.USD","BK4516","LU1989772923.USD","LU1791710400.SGD","LU2357305700.SGD","LU0006306889.USD","QTTB","LU2264538146.SGD","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638124507","title":"Press Release: Q32 Bio Announces $55 Million Private Placement Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2638124507","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638124507?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:00","pubTimestamp":1779883200,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., May 27, 2026 /PRNewswire/ -- Q32 Bio Inc.  , a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata  and other autoimmune and inflammatory diseases, today announced that it has entered into a securities purchase agreement with certain new and existing institutional and accredited investors for the private placement of common stock and pre-funded warrants for an aggregate of approximately $55 million.The private placement is being led by BVF Partners L.P., with participation from RA Capital Management, OrbiMed, and Atlas Venture.Q32 Bio is a clinical stage biotechnology company whose science targets potent regulators of the adaptive immune system to re-balance immunity and is focused on developing innovative therapies fo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4153","BK4585","AA","BK4588","LU2543165471.USD","BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637321100","title":"Zoom, Q32 Bio, Alcoa, Generac, Eos Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2637321100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637321100?lang=en_us&edition=fundamental","pubTime":"2026-05-23 17:01","pubTimestamp":1779526919,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($ZM) ), ( ($QTTB) ), ( ($AA) ), ( ($GNRC) ) and ( ($EOSE) ). Here is a breakdown of their recent","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/zoom-q32-bio-alcoa-generac-eos-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/zoom-q32-bio-alcoa-generac-eos-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","BK4554","BK4588","QTTB","BK4528","BK4532","EOSU","BK4525","AA","BK4096","BK4153","BK4535","BK4613","LU2394011477.USD","LU0823414478.USD","BK4548","ZM","LU1861558580.USD","LU2543165471.USD","LU1878469433.USD","BK4585","EOSE","BK4139","LU2249611893.SGD","BK4505","BK4551","GNRC","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637315319","title":"Q32 Bio Inc : Mizuho Initiates Coverage With Outperform Rating; Target Price $14","url":"https://stock-news.laohu8.com/highlight/detail?id=2637315319","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637315319?lang=en_us&edition=fundamental","pubTime":"2026-05-22 18:39","pubTimestamp":1779446376,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z0DP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637395298","title":"U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday","url":"https://stock-news.laohu8.com/highlight/detail?id=2637395298","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637395298?lang=en_us&edition=fundamental","pubTime":"2026-05-22 14:49","pubTimestamp":1779432553,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, WorkdayMay 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Jazz P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nL4N41Z0HR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMT","ELIS","CRBP","NUE","RTYY","HLNE","JAZZ","ROST","MVLL","NCLH","LLII","SUI","CLF","WMT","RIOT","LLYX","WDAY","FCX","ELIL","WMTI","WMS","MRVU","MP","ZM","SCCO","NEM","MTSI","TOL","EL","INTU","STLD","MAIN","FENC","FDX","AAP","WSM","DE","CMC","BEAT","FRT","LLY","RL","TGT","DLLL","DELL","EHC","MRVL","SPG","NEMG","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636727400","title":"Q32 Bio Initiated at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2636727400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636727400?lang=en_us&edition=fundamental","pubTime":"2026-05-18 23:29","pubTimestamp":1779118140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QTTB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 18, 2026 11:29 ET (15:29 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636027129","title":"Q32 Bio initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2636027129","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636027129?lang=en_us&edition=fundamental","pubTime":"2026-05-18 18:52","pubTimestamp":1779101552,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald initiated coverage of Q32 Bio (QTTB) with an Overweight rating. Published first on TheFly – the ultimate source for real-time, ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/q32-bio-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/q32-bio-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633139899","title":"Q32 Bio Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633139899","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633139899?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:34","pubTimestamp":1778074440,"startTime":"0","endTime":"0","summary":"Q32 Bio Inc reports results for the quarter ended March 31 - Earnings SummaryQ32 Bio Inc QTTB.OQ reported a quarterly adjusted loss of 54 cents per share for the quarter ended March 31, higher than th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL8N41J25B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.q32bio.com","stockEarnings":[{"period":"1week","weight":-0.0902},{"period":"1month","weight":-0.0187},{"period":"3month","weight":1.1805},{"period":"6month","weight":2.8634},{"period":"1year","weight":7.934},{"period":"ytd","weight":2.875}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.1396},{"period":"6month","weight":0.0895},{"period":"1year","weight":0.2014},{"period":"ytd","weight":0.1017}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction in the United States. Its lead product candidate is ADX-097, a humanized anti-C3d monoclonal antibody fusion protein to restore complement regulation, which has completed Phase I clinical trial for the treatment of renal and other complement-mediated diseases of high unmet need, including lupus nephritis, immunoglobulin A nephropathy, complement component 3 glomerulopathy, and anti-neutrophil cytoplasmic antibody-associated vasculitis. The company is also developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin that is Phase II clinical trial for the treatment of atopic dermatitis and alopecia areata. Q32 Bio Inc. was formerly known as AdMIRx Inc. and changed its name to Q32 Bio Inc. in April 2020. The company was founded in 2017 and is based in Waltham, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.019777},{"month":2,"riseRate":0.5,"avgChangeRate":0.070572},{"month":3,"riseRate":0.25,"avgChangeRate":-0.062438},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.082275},{"month":5,"riseRate":0.555556,"avgChangeRate":0.111875},{"month":6,"riseRate":0.555556,"avgChangeRate":0.01181},{"month":7,"riseRate":0.555556,"avgChangeRate":0.199498},{"month":8,"riseRate":0.5,"avgChangeRate":-0.023542},{"month":9,"riseRate":0.625,"avgChangeRate":0.034806},{"month":10,"riseRate":0.25,"avgChangeRate":-0.055418},{"month":11,"riseRate":0.375,"avgChangeRate":-0.113432},{"month":12,"riseRate":0.625,"avgChangeRate":-0.026783}],"exchange":"NASDAQ","name":"Q32 Bio Inc.","nameEN":"Q32 Bio Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Q32 Bio Inc.(QTTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Q32 Bio Inc.(QTTB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Q32 Bio Inc.,QTTB,Q32 Bio Inc.股票,Q32 Bio Inc.股票老虎,Q32 Bio Inc.股票老虎国际,Q32 Bio Inc.行情,Q32 Bio Inc.股票行情,Q32 Bio Inc.股价,Q32 Bio Inc.股市,Q32 Bio Inc.股票价格,Q32 Bio Inc.股票交易,Q32 Bio Inc.股票购买,Q32 Bio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Q32 Bio Inc.(QTTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Q32 Bio Inc.(QTTB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction